Multi-disciplinary diagnosis and treatment of a malignant pheochromocytoma with multiple metastases

Ya-wen Zheng, Xinwei Zhang, Z. Zhan, Zhaoxiang Ye, Wengui Xu, P. Wang, Zhi Guo, X. Yao, G. Xie, Dingzhi Huang, X. Ren
{"title":"Multi-disciplinary diagnosis and treatment of a malignant pheochromocytoma with multiple metastases","authors":"Ya-wen Zheng, Xinwei Zhang, Z. Zhan, Zhaoxiang Ye, Wengui Xu, P. Wang, Zhi Guo, X. Yao, G. Xie, Dingzhi Huang, X. Ren","doi":"10.3969/J.ISSN.1000-8179.20131397","DOIUrl":null,"url":null,"abstract":"9 Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China Abstract Malignant pheochromocytomas are rare tumors that arise from chromaffin tissue, and the diagnostic criterion of malig- nancy is based on the development of metastases. In the case a patient suffers the tumor with liver, lung and bone metastases. However, the test results of tumor markers, gastroscopy, chest and abdominal CT, and PET-CT examination are hard to make a definite diagnosis. The patient was finally diagnosed with malignant pheochromocytoma with liver, lung and bone metastases following the needle biopsy of liver and underwent the excision of a right adrenal pheochromocytoma. Therapeutic standard for the malignant pheochromocytomas is not available so far. It is reported that chemotherapeutic CVD regimen (cyclophosphamide, vincristine, and daecarbazine) and suni- tinib may be effectual in the alike cases. The patient received two cycles of CVD and one cycle of sunitinib, nevertheless, slow progres- sion of the disease remained after the treatment. The results of multi-disciplinary treatment have suggested that 131I-MIBG may just be a choice for this patient.","PeriodicalId":314105,"journal":{"name":"Clinical Oncology and Cancer Research","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Oncology and Cancer Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3969/J.ISSN.1000-8179.20131397","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

9 Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China Abstract Malignant pheochromocytomas are rare tumors that arise from chromaffin tissue, and the diagnostic criterion of malig- nancy is based on the development of metastases. In the case a patient suffers the tumor with liver, lung and bone metastases. However, the test results of tumor markers, gastroscopy, chest and abdominal CT, and PET-CT examination are hard to make a definite diagnosis. The patient was finally diagnosed with malignant pheochromocytoma with liver, lung and bone metastases following the needle biopsy of liver and underwent the excision of a right adrenal pheochromocytoma. Therapeutic standard for the malignant pheochromocytomas is not available so far. It is reported that chemotherapeutic CVD regimen (cyclophosphamide, vincristine, and daecarbazine) and suni- tinib may be effectual in the alike cases. The patient received two cycles of CVD and one cycle of sunitinib, nevertheless, slow progres- sion of the disease remained after the treatment. The results of multi-disciplinary treatment have suggested that 131I-MIBG may just be a choice for this patient.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
恶性嗜铬细胞瘤多发转移的多学科诊断与治疗
摘要恶性嗜铬细胞瘤是一种罕见的发生于嗜铬细胞组织的肿瘤,其恶性的诊断标准主要取决于肿瘤是否发生转移。在这种情况下,患者患有肝脏,肺部和骨骼转移的肿瘤。但肿瘤标志物、胃镜检查、胸腹CT、PET-CT检查等检测结果难以明确诊断。患者经肝穿刺活检最终确诊为恶性嗜铬细胞瘤伴肝、肺、骨转移,并行右侧肾上腺嗜铬细胞瘤切除术。恶性嗜铬细胞瘤的治疗标准至今尚无。据报道,化疗CVD方案(环磷酰胺、长春新碱和去氨卡巴嗪)和舒尼替尼可能对类似病例有效。患者接受了两个周期的心血管疾病治疗和一个周期的舒尼替尼治疗,然而,治疗后疾病进展缓慢。多学科治疗的结果表明,131I-MIBG可能正是该患者的一种选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
吲哚胺-2 3-双加氧酶对血液系统肿瘤治疗与预后的意义 Expression and significance of LAPTM4B-35 and MMP-9 in patients with gastric cancer Expression and diagnostic value of serum miR-26a/b in patients with gastric cancer Research progress on Rad51C in DNA damage repair Expression and significance of PARP1 and PAR in triple-negative breast cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1